Ironwood Investment Counsel’s Teradyne TER Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.5M Sell
25,312
-10,025
-28% -$2.8M 1.08% 23
2025
Q4
$6.84M Sell
35,337
-7,360
-17% -$1.26M 0.96% 27
2025
Q3
$5.88M Buy
42,697
+3,017
+8% +$330K 0.86% 35
2025
Q2
$3.57M Buy
39,680
+5,693
+17% +$455K 0.55% 49
2025
Q1
$2.81M Sell
33,987
-10,151
-23% -$1.14M 0.49% 59
2024
Q4
$5.56M Sell
44,138
-665
-1% -$78.7K 0.95% 31
2024
Q3
$6M Buy
44,803
+491
+1% +$66.2K 1% 29
2024
Q2
$6.57M Buy
44,312
+1,421
+3% +$180K 1.17% 20
2024
Q1
$4.84M Buy
42,891
+2,054
+5% +$214K 0.84% 41
2023
Q4
$4.43M Buy
40,837
+537
+1% +$50.9K 0.83% 40
2023
Q3
$4.05M Buy
40,300
+6
+0% +$633 0.85% 39
2023
Q2
$4.49M Buy
40,294
+2,234
+6% +$224K 1.01% 34
2023
Q1
$4.09M Buy
38,060
+3,025
+9% +$309K 0.97% 32
2022
Q4
$3.06M Sell
35,035
-1,490
-4% -$128K 0.74% 48
2022
Q3
$2.74M Buy
36,525
+4,109
+13% +$375K 0.78% 43
2022
Q2
$2.9M Buy
32,416
+2,721
+9% +$283K 0.82% 39
2022
Q1
$3.51M Buy
29,695
+20,403
+220% +$2.58M 0.86% 36
2021
Q4
$1.52M Buy
+9,292
New +$1.31M 0.35% 68

Other funds holding TER

Ironwood Investment Counsel's TER Position: Q1 2026 in Review

Ironwood Investment Counsel reduced its Teradyne (TER) stake by 28% in Q1 2026, selling an estimated $2.8M and leaving 25,312 shares worth $7.5M. The position accounts for 1.08% of the portfolio, ranked #23.

Ironwood Investment Counsel first reported a position in TER in Q4 2021 and has held it in 18 quarters since. 1,224 funds tracked by Wall St. Rank hold TER as of Q1 2026.

  • Ironwood Investment Counsel held 25,312 shares of Teradyne worth $7.5M as of Q1 2026.
  • Ironwood Investment Counsel sold 10,025 Teradyne shares in Q1 2026, an estimated $2.8M.
  • Teradyne made up 1.08% of Ironwood Investment Counsel's portfolio in Q1 2026, its #23 holding.
  • Ironwood Investment Counsel first reported a position in Teradyne in Q4 2021 and has held it in 18 quarters since.
  • 1,224 funds tracked by Wall St. Rank held Teradyne as of Q1 2026.

Based on Ironwood Investment Counsel's 13F filing for Q1 2026, filed 7 May 2026.